8
Jul 2026
Stem cell transplantation (also called bone marrow transplantation) and gene therapy are among the most powerful curative approaches for blood diseases such as sickle cell disease, b-thalassemia, immune deficiencies, and some blood cancers.
8
Jul 2026
For the first time, two teleoperated humanoid robots have been used to complete two surgeries during a preclinical trial, researchers report in the July 8 issue of the journal Nature.
8
Jul 2026
Rice University's Synthesis X Center and Houston Methodist Neal Cancer Center have awarded $90,000 in seed grants as part of a new strategic collaboration.
8
Jul 2026
Mass General Brigham, Boston University, and the Concussion & CTE Foundation cohort study of nearly 20,000 NFL players reveals that players are dying of dementia and Parkinson's disease at much higher rates than the general population.
8
Jul 2026
A few tears may someday reveal important clues about a person's neurological health. Researchers reporting in ACS Omega developed a low-cost electrochemical sensor designed to detect dopamine, a neurotransmitter involved in movement, learning, motivation, and emotional regulation.
8
Jul 2026
A project led by the University of Barcelona, GenAIMIX, will develop new generative artificial intelligence (AI) assistants for hospitals with limited resources, with the aim of improving healthcare in countries with limited financial resources.
8
Jul 2026
Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the University of California, San Francisco (UCSF), and funded in part by the National Institute of Mental Health (NIMH), adds to growing literature on the potential benefit of a ketogenic diet for treating psychotic disorders.
8
Jul 2026
An international team has published a new guideline for diagnosing and treating the rare genetic disease. It serves as a tool for everyone who treats and cares for patients affected by it.
8
Jul 2026
Gabriel Lázaro-Muñoz, PhD, JD, and Amanda R. Merner, PhD, of the Health Technology Performance Lab within the Mass General Brigham Neuroscience Institute, are the authors of a paper published in The American Journal of Psychiatry, "Implantable Neuromodulation Devices in Psychiatry: Human Fidelity and Implementation Challenges."
8
Jul 2026
Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
